In collaboration with G–CSF, tumor cell-derived CCL2 educated neutrophils to migrate into pre-metastatic lung and to produce HOCl, thereby inhibiting breast cancer seeding to lungs [164], probably by acting on TRPM2 expressed in tumor cells [102]. The gene discussed is CSF3; the disease is breast carcinoma.